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Abstract 
 The Chp chemosensory system plays a central role in detecting host signals and 
activating virulence gene expression, allowing the opportunistic bacterial pathogen 
Pseudomonsa aeruginosa to cause a wide array of diseases. Specifically, the Chp system 
controls production of intracellular cyclic AMP (cAMP) and type IV pilus mediated 
surface motility (twitching motility). cAMP serves as an allosteric activator of the 
transcription factor Vfr, a global regulator of virulence gene expression. A central 
component of the Chp chemosensory system is the hybrid ChpA kinase. In addition to a 
two stand alone receiver domains PilG and PilH, ChpA is composed of a conserved 
kinase domain, a serine-containing phosphotransfer domain (Spt 1), a threonine-
containing phosphotransfer domain (Tpt 1), six histidine-containing phosphotransfer 
domains (Hpt 1-6), and a CheY-like receiver domain (ChpArec). We hypothesized that 
multiple domains may be necessary to fine-tune signal transduction for twitching motility 
and/or intracellular cAMP levels.  
As a first step in assessing function, we used a biochemical approach to determine 
which ChpA domains were capable of participating in phosphotransfer events. We found 
that the Hpt 2 and 3 domains could only reversibly receive phosphoryl groups from 
ChpArec rather than ATP and Hpt 3 was able to transfer phosphoryl to PilH. Further, we 
found that ChpArec could both accept phosphoryl groups and transfer phosphoryl groups 
to Hpt 2-6. Based on these results, we generated point mutations in Hpt 2, 3 and ChpArec 
domains in all possible combinations and evaluated the impact on cAMP signaling and 
twitching motility. To assess cAMP signaling, we used a synthetic chromosomal 
transcriptional reporter system that reflects intracellular cAMP levels and Vfr activation.  
Mutant alleles were introduced onto the chromosome and confirmed by 
sequencing or expressed from plasmid in a chpA deletion strain. Western blot analysis 
was used to confirm stability and wildtype expression level of the mutant proteins. Using 
this approach, we found that mutation of Hpt 2 and 3 domains had opposing effects on 
cAMP signaling and twitching motility. Loss of ChpArec significantly decreased 
twitching motility and increased cAMP production. Lastly, Hpt3 phenocopied a PilH 
mutant while a Hpt23 double mutant phenocopied a Hpt 2 single mutant in cAMP 
production and twitching motility. We are currently testing the impact of additional 
combination mutations. Overall, the mechanism of phosphotransfer in the P. aeruginosa 
ChpA kinase was deduced via in vitro and in vivo methods that shed new light on a 
complex system that mediates type IV pili bacterial motility.  
 
 
 
 
 
 
 
 
 
 
 
 
I. INTRODUCTION 
 Pseudomonas aeruginosa is an opportunistic, Gram-negative pathogen which 
causes infections in animals, plants, and humans (Driscoll, et al., 2007). The hospitalized 
population, immunocompromised individuals and those with chronic airway diseases 
such as cystic fibrosis and chronic obstructive pulmonary disease are at the most risk for 
infection (Giamarellou, 2000). P. aeruginosa is responsible for nearly 10% of all 
hospital-acquired infections, which are often life-threatening because of the bacteria’s 
high levels of antibiotic resistance (NNISS, 2004). P. aeruginosa is found commonly in 
nature and thrives in moist environments such as respiratory equipment, antiseptic 
solutions, sink taps, and showers (Giamarellou, 2000).  
P. aeruginosa responds to unknown host associated cues by expressing virulence 
factors. The Pil-Chp chemosensory system, a type of two-component system (TCS), 
plays a central role in detecting host signals and activating virulence gene expression, 
allowing P. aeruginosa to cause a wide array of diseases. A central component of the Pil-
Chp chemosensory system is the ChpA kinase, a homologue of the CheA kinase. As 
illustrated in Figure 1, ChpA is a very large, complex signal transduction protein. In 
addition to two separate CheY-like receiver domains PilG and PilH, ChpA contains eight 
Xpt phosphotransfer domains and a C-terminal receiver domain (ChpArec) (Leech, 
Mattick, 2006). The chpA gene is linked to several other complex virulence pathways in 
P. aeruginosa, namely cyclic AMP production and type IV pilus (T4P) mediated 
twitching motility.  
 Figure 1. The ChpA is a highly complex hybrid histidine kinase.  
The second-messenger signaling molecule adenosine 3’, 5’-cyclic monophosphate 
(cAMP or cyclic AMP) regulates many virulence factors (Wolfgang, et al., 2003). It is 
synthesized by the adenylate cyclase CyaB, whose activity is controlled by the Chp 
system (Fulcher, et al., 2010). Once produced, cAMP binds to and activates the 
transcription factor Vfr (virulence factor regulator) and creates a cAMP-Vfr complex 
(West et al., 1994). The cAMP-Vfr complex regulates various virulence factors that 
instigate secretion of toxins and host colonization. Further, the Pil-Chp system, similar to 
flagellar-based chemotaxis systems, has been shown to regulate twitching motility, 
resulting from the extension and retraction of T4P (Rauprich, et al., 1996).  
 The typical TCS features His->Asp phosphotransfer between a signal-sensing 
histidine kinase and the receiver domain of a partner response regulator, whereby the 
phosphorylated response regulator executes an output response. In contrast to the E. coli 
flagellar chemotaxis protein CheA, P. aeruginosa ChpA has nine possible 
phosphorylation sites and two potential partner CheY-like receiver proteins that 
complicate the signaling strategy of the Chp chemosensory system. Recent research has 
demonstrated that, of the eight Xpt domains, three (Hpts 4, 5, 6) could be 
270kDa 
2478aa 
H1 T H6 H2 H5 H4 S H3 D1 Dimer His Kin CheW 
ChpA 
D2 D3 
PilG PilH 
autophosphorylated with ATP. These same Hpts plus two others- Hpt2 and Hpt3- could 
become reversibly phosphorylated by the ChpA C-terminal receiver domain (ChpArec). 
The remaining Xpts (Hpt1, Spt, and Tpt) displayed no detectable phosphotransfer 
reactivity. Phosphoryl groups transferred rapidly from all five of the phosphorylated Hpts 
to ChpArec, but phosphorylation of PilG and PilH was slower. These in vitro studies 
demonstrated that ChpArec could act as either a phosphate sink or a source of phosphoryl 
groups for the phosphorylatable Hpts (Silversmith et al., under review).  
 
Figure 2. Scheme summarizing phosphotransfer between Pil-Chp domains. The 
length of the arrow reflects the relative reactivity. Gray arrows reflect presumed variation 
of Hpt autophosphorylation by the presence of stimulus. Solid black arrows reflect 
inherent rates measured here. Dashed arrows indicate the absence of rapid 
phosphotransfer (experimental design precluded measurement of slower 
phosphotransfer). The actual rate is a function of the inherent reactivity and the local 
concentration of reactants. 
 In this report, we seek to examine the biochemical pathway by which each 
phosphotransfer domain of ChpA system controls cAMP-dependent virulence systems 
and twitching motility via type IV pili. First, alanine substitution mutants were generated 
at the predicted phosphorylation sites of the ChpA receiver domain (chpArecDA), Hpt 2 
domain (chpAHpt2HA), Hpt 3 domain (chpAHpt3HA), both Hpt 2 and receiver domain 
(chpAHpt2HArecDA), and both Hpt 3 and receiver domain (chpAHpt3HArecD2A) were 
created in P. aeruginosa strain PAKΔcyaAlacP1:ΔlacI-lacZ. The strain contains a 
deletion of the minor adenylate cyclase cyaA and a synthetic lacP1:ΔlacI-lacZ reporter 
system that is used as a surrogate readout for intracellular cAMP production based on the 
E. coli lacP1 promoter. Then, β-galactosidase assays were performed on these strains to 
indirectly measure intracellular cAMP levels with corresponding western blots to 
quantify ChpA protein levels. Finally, twitching motility assays were used to identify 
domain specific effects on twitching. We conclude that the ChpA receiver domain acts as 
a phosphate sink which prevents ChpA from activating downstream pathways until an 
appropriate signal threshold is achieved. Finally, the Hpt phosphotransfer domains, 
namely Hpt 2 and 3, serve to further attenuate phosphate transfer within a complex 
chemosensory-like two component system necessary for bacterial cell motility.  
 
 
 
 
II. MATERIALS AND METHODS 
Construction of P. aeruginosa ChpA Hpt 2HA and 3HA chromosomal mutants for 
in vivo studies. 
For in vivo studies of chpAHpt2HA and chpAHpt3HA mutants were created via 
Quickchange methodology (Agilent Technologies) and cloned via Gateway Technology 
(Invitrogen) into PAKΔcyaAlacP1:ΔlacI-lacZ. First, a large portion of the chpA gene 
containing the domains in question was amplified using the primers 5’ Hpt2_3_frag (5’ 
TACAAAAAAGCAGGCTAGCGACGACAACTGGACCCTTG) and 3’ Hpt2_3_frag 
(3’ TACAAGAAAGCTGGGTCGACACCATTTCCTCGTCCAGC) from a full-length 
chpA expression plasmid pJNTac4:ChpA. Attachment sites AttB were added to the 
termini of the amplicon allowing recombination into vector pDONR201 via a Gateway 
Cloning Technology BP recombination reaction. The Hpt 2 and 3 site were mutated from 
a histidine to alanine codon via Quikchange methodology reaction and sequence 
confirmed.  
Then, the mutagenized fragments were moved by LR recombination reaction to 
the P. aeruginosa destination suicide vector pEXG2GW. Finally, the mutant suicide 
vector was mated with P. aeruginosa strain PAKΔcyaAlacP1:ΔlacI-lacZ to generate 
mutants in an otherwise wild type strain with a reporter system to indirectly measure 
cAMP. Further, Hpt 2 and 3 single and double mutants were cloned into the 
PAKΔcyaAchpArecDAlacP1:ΔlacI-lacZ background. Each mutant was confirmed by 
sequencing and restriction enzyme digest.  
 
Construction of P. aeruginosa ChpArecDA chromosomal mutant for in vivo studies. 
A chpArecD2407A (chpArecDA) substitution mutant was cloned via Gateway 
Technology (Invitrogen) into PAKΔcyaAlacP1:ΔlacI-lacZ. The 3’ region of chpA was 
amplified as two separate but overlapping sequences, such that the overlapping sequences 
introduced a D2407A codon substitution. The 5’ fragment was amplified using primers 
5’chpArecD2407A (5’ 
TACAAAAAAGCAGGCTACCTCAGCGATCATGAAGTGCTGC) and 
pJNt4chpArec3’ (5’ GCGCGGCATCTCGATGGCCAGCAGGAGGATGTC). The 3’ 
fragment was amplified using primers 5’ pJNt4chpArec (5’ 
GACATCCTCCTGCTGGCCATCGAGATGCCGCGC) and 3’ chpArecD2407A (5’ 
TACAAGAAAGCTGGGTGCGGACGTTCTTCACATGCCACTG). Attachment sites 
AttB were added to the amplicon and inserted into vector pDONR201 via a BP 
recombination reaction. 
An LR recombination reaction with the pDONR201 entry clone mutant and 
destination vector pEXG2GW was performed to generate a suicide vector. Finally, the 
mutant suicide vector was mated with PAKΔcyaAlacP1:ΔlacI-lacZ to generate mutants in 
wild type PAK with a reporter system to indirectly measure cAMP. Each mutant was 
confirmed by sequencing and restriction enzyme digest.  
 
Construction of P. aeruginosa ChpA expression plasmids for in vivo studies. 
 For in vivo expression of wildtype chpA and chpArec D2407A, we engineered an 
improved expression plasmid (pJNtac4) that confers gentamycin resistance, high copy 
number in E. coli, an IPTG controlled PTOP promoter for titratable expression of 
payload genes and mobilization elements for conjugal transfer between E. coli and P. 
aeruginosa. To generate pJNtac4, the lacIq-PTOP control region of pMMBV4 (21) was 
amplified with primers lacIqtacP 5’ 
(5’TAATGAATTACAACAGTTTTTATGCATGCTGCTCCCGAACGCCAGCAAGAC
G) and lacIqtacP 3’ 
(5’CTAGTGGATCCCCCGGGCTGCAGGAATTCTGTTTCCTGTGTGAAATTGTTA
TC). Underlined nucleotides correspond to pJN105 vector sequence adjacent to and 
including SphI and EcoRI restriction sites, respectively. The resulting amplicon was 
cloned by Gibson Assembly (New England Biolabs) into pJN105 linearized by restriction 
enzyme digest with SphI and EcoRI to remove the araC-PBAD expression control 
region. Proper assembly of the resulting pJNtac4 vector was confirmed by sequencing. 
For complementation, the full-length (ATG-TGA) chpA open reading frame (ORF) was 
PCR amplified from PAK genomic DNA using primers 5’chpA 
(5’ATAACAATTTCACACAGGAAACAGAATTCgaggaggatattcATGGGTGACCGG
CACGACTACGTCGCTC) and 3’chpA 
(5’CGACTCACTATAGGGCGAATTGGAGCTCTCACTCATGCTGGCCGACCAG
GGACTGG). Underlined nucleotides correspond to pJNtac4 vector sequence adjacent to 
and including EcoRI and SacI restriction sites, respectively. Lowercase italic sequence 
represents a synthetic ribosome binding site and spacer region. Bold sequences 
correspond to the 5’ and 3’ termini of the chpA ORF, respectively. The resulting 
amplicon was gel purified and cloned by Gibson Assembly (New England Biolabs) into 
pJNtac4 linearized by restriction enzyme digest with EcoRI and SacI, such that cloned 
chpA expression was under the control of the adjacent IPTG controlled PTOP promoter. 
Integrity of the resulting expression plasmid, pJNTac4-chpA, was confirmed by double 
stranded sequencing. To generate a ChpArec D2407A substitution mutant, the 3’ region 
of chpA was amplified as two separate but overlapping fragments, such that the 
overlapping sequences introduced a D2407A codon substitution (GAC to GCC). The 5’ 
fragment was amplified using primers pJNt4chpA5’KpnI 
(5’CGCATGGTGCCGTTCGATCGGCTGGTACCG) and pJNt4chpArec 3’ (5’- 
GCGCGGCA TCTCGA TGGCCAGCAGGAGGA TGTC). The 3’ fragment was 
amplified using pJNt4chpArec 5’ (5’- GACA TCCTCCTGCTGGCCA TCGAGA TGCC 
GCGC) and pJNt4chpA3’Bsu36I (5’ CTCCACGGGGAGAGCCTGAGCAAACTGGC 
C). The D2407A codon substitution is indicated in bold in the overlapping internal 
primers. The resulting products were spliced by overlap extension PCR using the 
flanking primers pJNt4chpA5’KpnI and pJNt4chpA3’Bus36I. The flanking primers 
correspond to pJNtac4-chpA vector sequence adjacent to and including KpnI and Bsu36I 
restriction sites, respectively. The spliced product, encompassing the 3’ region of chpA 
and encoding the D2407A substitution, was cloned by Gibson Assembly into pJNtac4-
chpA digested with KpnI and Bsu36I to generate pJNtac4-chpArec D2407A. The 
resulting plasmid was confirmed by sequencing.  
In vivo expression of ChpA rec D2407A and P. aeruginosa phenotype assays 
 All chpA in vivo expression and phenotyping experiments utilized 
previously described derivatives of P. aeruginosa strain PAK (Fulcher, et al., 2010). 
Twitching motility and cAMP reporter assays were performed as previously described 
(Fulcher, et al., 2010). For routine passage, E. coli and P. aeruginosa strains were 
maintained at 37°C in LB broth or on LB agar. pJNtac4-based expression plasmids were 
transferred to P. aeruginosa by conjugation and maintained by selection with 75 µg ml-1 
gentamycin. For protein expression of pJNtac4-based expression plasmids, IPTG was 
included in the growth media at the indicated concentration. Chromosomal mutants were 
all grown in LB broth or on LB agar without selection. Growth was monitored by OD at 
600 nm. For western blots, whole cell lysates were prepared from culture aliquots 
obtained at OD600 = 0.5-1.0 as previously described (Fulcher, et al., 2010). Proteins 
were separated on 4-15% gradient SDS- polyacrylamide gels (BioRad), transferred to 
nitrocellulose and simultaneously probed with rabbit anti-ChpA sera and mouse 
monoclonal antibody specific for the beta subunit of RNA polymerase (RNAP) 
(NeoClone). ChpA anti-serum was generated in rabbits immunized with purified ChpA 
construct (Cocalico Biologicals). Anti-RNAP antibody was included as a loading and 
normalization control as previously reported (Topal, H. et al., 2012). Antigen-antibody 
complexes were detected using goat anti-rabbit IRDye800CW and goat anti- mouse 
IRDye680LT (LI-COR) and visualized using a LI-COR Odyssey Classic Infrared 
Imaging System and Odyssey Software version 3.0. ChpA and RNAP band intensity was 
quantified using ImageJ ((Topal, H. et al., 2012, Schneider, C. A., et al., 2012). 
 
 
 
 
 
 
III. RESULTS AND DISCUSSION 
A. RESULTS 
ChpArec acts as a phosphate sink- In P. aeruginosa, twitching motility and intracellular 
cAMP production are dependent on ChpA and its corresponding, free floating receiver 
proteins PilG and PilH (Fulcher, et al., 2010). A third receiver, ChpArec, has been shown 
to both rapidly and reversibly react with ChpA Hpt 2-6 domains and 
autodephosphorylates (transfer of the phosphoryl group to water) these domains faster 
than PilG or PilH (Silversmith et al., under review). The ChpArec domain is also the 
primary means for phosphorylation of Hpt 2 and Hpt 3. We hypothesized ChpA rec could 
act as either a phosphate sink, acting to keep phosphoryl groups off PilG and PilH or a 
source of phosphoryl groups for the phosphorylatable Hpts. In order to test the in vivo 
effects based upon biochemical analyses, we measured twitching motility and 
intracellular cAMP production in a P. aeruginosa strain containing a ChpA substitution 
mutant that lacked the receiver domain site of phosphorylation (ChpA rec D2407A or 
ChpArecDA).  
First, we compared wildtype strain PAK, an isogenic chpA non-polar deletion 
mutant as a negative control (ΔchpA), and the ΔchpA mutant complements with plasmid 
encoded ChpA or ChpArecDA. To ensure cAMP levels derived only from ChpA activity, 
all strains contained a deletion of the minor adenylate cyclase gene cyaA (ΔcyaA) and 
carried a chromosomal copy of the quantitative cAMP-depdendent transcriptional 
reporter (lacP1ΔlacI-lacZ) to indirectly measure cAMP levels. For complementation, an 
expression plasmid pJNtac4 containing full length chpA or chpArecDA substitution 
mutant under the control of an IPTG-inducible promoter was constructed (see Methods).  
The chpA deletion mutant had drastically reduced levels of intracellular cAMP 
and twitching motility compared to wildtype, but IPTG induced plasmid-expressed chpA 
(pJNtac4-chpA) was able to restore wildtype levels. In contrast, plasmid-expressed 
ChpArecDA showed a significant defect (p<0.001) in twitching motility and about 
twofold increase in cAMP production (p<0.001) compared to wildtype (Figures 3 and 4). 
Western blot analysis demonstrates that plasmid expression of ChpA and ChpArecDA 
resulted in proteins levels that were indistinguishable from that of the wildtype strain 
(Figure 5).  
Subsequently, a chromosomal ChpArecDA mutant was also constructed and 
resulted in similar defects in cAMP production and twitching (Figures 6 and 7). Finally, 
strains containing a double mutation with either Hpt2 and ChpA substitutions 
(ChpAHArecDA) or Hpt 3 and ChpA substitutions (ChpAHArecDA) were constructed. 
Both double mutant strains behaved more similarly to the ChpArec single mutant than the 
wild type strain for both cAMP production and twitching motility (Figures 6 and 7). 
Taken together, genetic phenotypes indicate that inactivation of the ChpA 
receiver domain decreases twitching motility via type IV pili function while increases 
cAMP synthesis. In comparison, of the two other receiver domains in the Pil-Chp system, 
ChpArec behaves similar to PilH (decreased twitching and increased cAMP). Previously, 
these behaviors have been attributed to PilH acting as a phosphate sink. These results 
show that the dominate role of ChpArec, which is covalently linked to ChpA rather than 
freely floating like PilH, is to act as a phosphate sink. Further, these results indicate that 
ChpArec is not necessary for the transfer of phosphoryl groups to PilG in vivo. Finally, 
ChpArec has possible epistatic interactions with the Hpt 2 and 3 domains in cAMP 
production and twitching motility because the ChpArec phenotype dominated in the 
double mutant strains.  
 
cAMP phenotypes of Hpt2, Hpt3, and ChpArec phosphorylation site mutants reveal both 
gain and loss of function- Chemosensory systems specialized to mediate motility by T4P 
contain multiple phosphotransfer domains within their CheA analogues. ChpA is one of 
the only studied CheA with eight Xpt domains that can be separated into groups based 
upon reactivity. Previous in vivo studies indicate that both gain and loss of Pil-Chp 
function lead to reduced twitching motility. First, chpA and pilG deletion strains both 
display loss of function (low cAMP and reduced surface pilin relative to wild type), 
indicating phosphorylated PilG (PilGp) is necessary for cAMP production via regulation 
of the adenylate cyclase CyaB (Fulcher, 2010). In contrast, pilH deletion mutants display 
gain of function (elevated cAMP and surface pilin over wild type), indicating that PilH 
suppresses cAMP production (Fulcher, 2010). 
To assess the phenotype of the Hpt 2 and 3 domains in conjunction with the 
ChpArec domain, seven chromosomal nonphosphorylatable alanine substitutions of Hpt2, 
Hpt3, and ChpArec in all combinations were constructed in P. aeruginosa strain 
PAKΔcyaAlacP1:ΔlacI-lacZ (see methods). Similar strains as above were utilized in that 
all strains contained a deletion of the minor adenylate cyclase cyaA, a chromosomal 
cAMP-dependent transcriptional reporter, and assays included a wild type, negative 
control containing a chromosomal ChpA deletion, and previously assayed pilG and pilH 
mutants.  
First, both the Hpt3 and pilH mutant displayed 3-4 fold elevated cAMP 
production over wild type (Figure 6). This phenotype similarity supports the in vitro 
findings that Hpt3 rapidly transfers phosphoryl groups to PilH. Additionally, the Hpt 2 
mutant displayed reduced cAMP levels between that of the pilG mutant and wild type, 
indicating partial loss of function (Figure 6). Although in vitro analysis did not indicate 
phosphoryl group transfer from Hpt 2 to PilG, in vivo cAMP phenotypes support this 
connection. The observation that the hpt23HA double mutation diminishes cAMP to near 
the levels seen in the Hpt2HA mutant alone is also consistent with a model in which in 
the absence of Hpt3, phosphoryl groups are routed through Hpt2 to PilG and further that 
Hpt2 and Hpt3 represent routes of phosphoryl groups to PilG and PilH respectively. 
Lastly, the finding that Hpt2HA did not show the same degree of defect as the pilG 
deletion mutant is consistent with the fact that Hpt4, 5, 6 are capable of phosphotransfer 
to PilG. 
The double mutants ChpArecDA, Hpt2HA and ChpArecDA, Hpt3HA and the 
triple mutant ChpArecDA, Hpt2HA, Hpt3HA all had levels of cAMP that were 
indistinguishable from the ChpArecDA single mutant (Figure 6). This result indicates 
that Hpt2 and Hpt3 function downstream from ChpArec, which is consistent with the 
scheme assembled in Figure 2 (Introduction) from biochemical results.  In this scheme 
phosphoryl groups cannot reach Hpt2 or Hpt3 in either the ChpArecDA single mutant or 
the Hpt2HA, Hpt3HA double mutant.  The increased level of cAMP in the former mutant 
compared to the latter is consistent with loss of phosphoryl groups from the system by 
rapid autodephosphorylation of ChpArec when present. Lastly, western blot analysis of 
whole cell lysate samples of the assayed seven combination mutant strains was 
performed. In comparison to wild type ChpA expression levels, the chromosomal 
mutants displayed similar ChpA levels indicating that the mutant proteins were stable 
(Figure 8).  
 
Correlation of twitching and cAMP phenotypes- The same set of chromosomal mutants 
was evaluated for Type-IV pili mediated twitching motility. Twitching motility is a 
relatively insensitive measure of Pil-Chp output as it involves a complex interplay 
between pilus extension and retraction dynamics, such that gain-of-function and loss-of-
function mutations both result in suboptimal or reduced motility (Bertrand, 2010). 
Grouping mutants based on twitching motility gave the same groupings described above 
for cAMP phenotypes. 
The Hpt3HA and pilH mutants, which shared strong gain of function cAMP 
phenotypes (Figure 6), exhibited similar twitching defects with zone expansion rates 30-
40% of the wild type strain (Figure 7).  Likewise, all of the mutants containing the 
ChpArecDA substitution (ChpArecDA, ChpArecDA,Hpt2HA, ChpArecDA,Hpt3HA, 
and ChpArecDA,Hpt2HA,Hpt3HA), which shared similar modest gain of function cAMP 
phenotypes, gave the similar twitching rates of 50-60% of wildtype (Figure 7).  Thus the 
twitching data is also consistent with the ChpArec mutant being epistatic (upstream) to 
both Hpt2 and Hpt3. Finally, the Hpt2HA and Hpt2HAHpt3A mutants, which had similar 
cAMP phenotypes (diminished relative to wild type), also had similar twitching of 85-
90% wild type (Figure 7).   
 
 
B. DISCUSSION 
Bacterial chemosensory signal transduction systems that regulate motility by type 
IV pili often contain a CheA kinase with numerous potential sites of phosphorylation 
(Whitchurch, et al., 2004). Recently, novel signal mechanisms regarding a complex 
CheA homologue, the ChpA histidine kinase in P. aeruginosa are shown in Figure 2. The 
ChpA kinase is a central component of the Pil-Chp chemosensory system in P. 
aeruginosa which regulates cAMP production and T4P-mediated twitching motility, both 
of which play roles in pathogenesis. The ChpA kinase contains eight Xpt domains, a C-
terminal receiver domain (ChpArec) and interacts with two stand-alone receiver domains 
(PilG and PilH), each involved in a complex series of phosphotransfer steps. Notably, 
ChpArec reacted rapidly and reversibly with Hpt 2-6 and could potentially act as a 
phosphate sink due to its efficient autodephsophorylation or a source of phosphoryl 
groups for Hpt 2-6 or PilH. Moreover, the Hpt 2 and 3 domains could only receive 
phosphoryl groups from ChpArec rather than ATP, and appeared to transfer them to PilG 
and PilH, with Hpt3 to PilH being the fastest observed route (Silversmith et al., under 
review).  
Thus, in vivo experiments were conducted to evaluate the effect of single and 
combination mutations in the Hpt 2, 3 and rec domains. Both a chromosomal mutant of 
ChpArec and plasmid expressed full length ChpArecDA mutant showed a significant 
increase in cAMP production and decrease in twitching motility compared to wild type. 
Despite biochemical evidence showing multiple phosphotransfer reactivates for ChpArec, 
this in vivo analysis indicated that ChpArec functions primarily as a phosphate sink 
because it is covalently bound to ChpA and less likely to have its own target molecule. 
This is in contrast to previous data which showed there was no twitching in a ChpArec 
mutant (it behaved the same as a ΔchpA mutant) in a different strain PAO1 containing a 
chromosomal deletion mutant of chpA complemented with point mutated ChpArec in an 
expression plasmid (Leech, Mattick, 2006). However, partial twitching ability is expected 
because a mutant in another phosphate sink receiver domain PilH resulted in highly 
elevated cAMP levels but still displayed partial twitching and because there are still 
available phosphotransfer routes in ChpA (Fulcher, et al., 2010). 
Subsequently, single point mutants of the Hpt 2 and 3 domains were created on 
the chromosomal chpA gene. The Hpt2HA mutant displayed slightly lower cAMP levels 
with almost wild type levels of twitching while the Hpt3HA mutant displayed highly 
elevated cAMP levels with partial twitching ability. These phenotypes suggest the Hpt2 
domain aids in cAMP levels by providing phosphoryl groups for PilG. In contrast, the 
Hpt3 domain most likely supplies phosphoryl groups to PilH (and is consistent with 
biochemical analysis) or remove or prevent phosphoryl groups from reaching PilG. 
Lastly, the both double mutants of Hpt2HArecDA and Hpt3HArecDA mimic the 
ChpArecDA single mutant phenotype with about a twofold increase in cAMP production. 
This indicates the dominant role ChpArec plays over either Hpt 2 or 3 domain as it is 
upstream in the phosphotransfer mechanism of ChpA and further demonstrates either 
domain is not necessary for cAMP production.  
Taken together, previously reported genetic data (Fulcher, et al., 2010; Bertrand, 
et al., 2010) as well as the phenotypes of seven new mutants reported here are consistent 
with multiple fundamental features of the Chp/Pil signaling network deduced from our 
biochemical results. In particular, all genetic results are consistent with the intramolecular 
phosphoryl group flow within ChpA proposed here.  However, some aspects of the 
genetic data suggest the scheme based on biochemical results alone is incomplete.  In 
particular, the preferred in vivo routes of phosphotransfer between Hpts 2-6 and 
PilG/PilH may not have been identified by our in vitro experiments. We are currently 
testing the affects of the combination mutants on surface pilus protein expression levels. 
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VI. SUPPLEMENTAL DATA 
 
Figure 3. The ChpA receiver domain suppresses cAMP synthesis in P. aeruginosa. 
Mutation of the ChpA receiver domain site of phosphorylation from an aspartic acid to an 
alanine increase cAMP synthesis. Phenotypes were assayed for wildtype P. aeruginosa 
strain PAK (WT) carrying empty vector (pJNtac4) and an isogenic chpA deletion strain 
(ΔchpA) carrying empty vector or complemented with either plasmid-encoded wildtype 
ChpA (pJNtac4-chpA) or ChpA with an alanine substitution at the receiver domain site 
phosphorylation, ChpArec D2407A (pJNtac4-chpArec D2407A). Relative intracellular 
cAMP levels were determined by β-galactosidase assay of strains harboring a quantitative 
cAMP-dependent transcriptional reporter (lacP1ΔlacI-lacZ) (Fulcher, et al., 2010). Assay 
was performed in the presence of 75 µg/ml gentamycin for plasmid maintenance and 25 
µM IPTG for induction of plasmid expression of chpA alleles with three replicates. 
Asterisk represents significant difference form wild type (p<0.001).  
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 Figure 4. The ChpA receiver domain modulates twitching motility. Mutation of the 
ChpA receiver domain decreased twitching motility. The same strains were assayed as in 
Figure 3 with five replicates. Twitching motility measurements represent the diameter of 
subsurface zones of expansion 40 hours post inoculation of bacteria to the agar-plastic 
interface (Fulcher, et al., 2010). Asterisk represents significant difference form wild type 
(p<0.001).  
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 Figure 6. The ChpA phosphotransfer Hpt 2 and 3 domains and receiver domains 
work in conjunction to modulate cAMP phenotypes. Double and triple mutations of 
the Hpt2 and 3 domains in tandem with the receiver domain resemble the phenotype of 
the single receiver domain mutant. Single mutation of the Hpt 2 domain decreased 
cAMP, similar to a PilG mutant, and mutation of the Hpt 3 domain increased cAMP 
production, similar to a PilH mutant. A Hpt 23 double mutant phenocopies a Hpt 2 single 
mutant. Phenotypes were assayed for wild type PAK (WT), an isogenic chpA deletion 
strain (ΔchpA), a chromosomal ChpArec mutation (rec), a ChpA Hpt2 mutation (Hpt2), 
and ChpA Hpt 3 mutation (Hpt3) in all seven possible combinations. The PilG and PilH 
mutants were reported before but assayed here as a comparison. Relative intracellular 
cAMP levels were determined by β-galactosidase assay of strains harboring a quantitative 
cAMP-dependent transcriptional reporter (lacP1ΔlacI-lacZ) (Fulcher, et al., 2010). 
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 Figure 7. The Hpt 2, 3, and rec domains modulate twitching motility in correlation 
with cAMP phenotypes. All seven combinations of Hpt 2, 3, and rec domain mutants 
were assayed as in Figure 5. The same phenotype conclusions can be drawn and 
demonstrates there may need to be an optimal level of intracellular cAMP in order to 
display wild type twitching ability. Assay represents seven replicates. 
 
 
 
 
 
wt
Δc
hp
A
rec
DA
Hp
t2H
A
rec
DA
Hp
t2H
A
Hp
t3H
A
rec
DA
Hp
t3H
A
Hp
t23
HA
rec
DA
Hp
t23
HA
Δp
ilG
Δp
ilH
0
2
4
6
8
Tw
itc
hi
ng
 Z
on
e 
D
ia
m
et
er
 (c
m
)
   
Figure 5. The ChpA receiver domain mutant does not alter ChpA protein 
expression. Lane one is Precision Plus Protein Kaleidoscope ladder with 250kDA top 
band. Lane 2 is wild type PAK carrying empty vector (pJNtac4), lane two is an isogenic 
chpA deletion strain (ΔchpA) carrying empty vector, lane 3 is a chpA deletion strain 
complemented with plasmid-encoded wildtype ChpA (pJNtac4-chpA), lane 4 is a chpA 
deletion strain complemented with an alanine substitution at the receiver domain site 
phosphorylation, ChpArec D2407A (pJNtac4-chpArec D2407A). Green bands represent 
ChpA (260kDA) and red bands are an RNA polymerase standard. ChpA expression 
levels in lanes 3 and 4 are complemented to wild type ChpA in the presence of 75 µg/ml 
gentamycin for plasmid maintenance and 25 µM IPTG for induction of plasmid 
expression.  
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Figure 8. Mutation of multiple ChpA domains may modulate ChpA protein 
expression. Lane one is Precision Plus Protein Kaleidoscope ladder with 250kDA top 
band. Lane 2 is wild type PAK, lane 3 is an isogenic chpA deletion strain (ΔchpA), lane 4 
chromosomal ChpArecDA mutant, lane 5 is a chromosomal ChpA Hpt 2 mutant, lane 6 is 
a chromosomal ChpA recDA and Hpt 2 double mutant, lane 7 is a chromosomal ChpA 
Hpt 3 mutant, lane 8 is a chromosomal ChpA recDA and Hpt 3 double mutant, lane 9 is a 
Hpt23 double mutant, lane 10 is a Hpt23 rec triple mutant. Green bands were probed with 
a ChpA specific monoclonal antibody (260kDA) green bands were probed with a anti E. 
coli RNA polymerase anitbody. Strains were grown in plain LB and are whole cell 
lysates of those assayed in Figure 5.  	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